Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.
Filter Awards
| Disease | Cell Type |
Therapeutic or Technology |
Institution | Stage | Project Objective | Details |
|---|---|---|---|---|---|---|
|
Neurological Disorders, Zika virus |
Adult Stem Cell, iPS Cell |
Vaccine | UCLA |
 |
Development Candidate | |
| COVID-19 | Adult Stem Cell | Vaccine | Stanford |
|
Development Candidate, Proof of Concept | |
| COVID-19 | Adult Stem Cell | Vaccine | UCLA |
|
Development Candidate, Proof of Concept | |
| COVID-19 | Adult Stem Cell | Small molecule therapy | Stanford |
|
Development Candidate, Proof of Concept | |
| Vision Loss | iPS Cell | Small molecule therapy | UCSD |
|
Development Candidate, Proof of Concept | |
| Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Small molecule therapy | UCSD |
 |
Pre-IND/IDE or Equivalent | |
| Autism | iPS Cell | Small molecule therapy | Scripps |
|
Development Candidate, Proof of Concept | |
| COVID-19 | Adult Stem Cell | Small molecule therapy | UCLA |
|
Pre-IND/IDE or Equivalent | |
| Colon Cancer | Cancer Stem Cell | Small molecule therapy | UCSD |
|
Development Candidate, Proof of Concept | |
|
COVID-19, Respiratory Disorders |
iPS Cell | Small molecule therapy | Sanford-Burnham |
|
Development Candidate, Proof of Concept | |
| Skeletal/Smooth Muscle disorders | Adult Stem Cell | Small molecule therapy | Stanford |
|
Development Candidate | |
|
COVID-19, Respiratory Disorders |
iPS Cell | Small molecule therapy | UCLA |
|
Development Candidate, Proof of Concept | |
| COVID-19 | iPS Cell | Small molecule therapy | Scripps |
|
Development Candidate, Proof of Concept | |
| COVID-19 | iPS Cell | Small molecule therapy | USC |
|
Development Candidate, Proof of Concept | |
| Osteonecrosis | Adult Stem Cell | Small molecule therapy | UC Davis |
 |
Clinical Trial, Phase 1 or Phase 1/2 | |
|
Arthritis, Osteoarthritis |
Adult Stem Cell | Small molecule therapy | Calibr |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Hearing Loss | Adult Stem Cell | Protein/peptide therapy | Stanford |
|
Development Candidate, Proof of Concept | |
| Corneal Damage | Adult Stem Cell | Personalized cell therapy | UCLA |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Intervertebral disc degeneration | Adult Stem Cell | Personalized cell therapy | Ankasa |
 |
IND | |
| Heart Disease | iPS Cell | Personalized cell therapy | UC Davis |
|
Proof of Concept | |
| Multiple Myeloma | Adult Stem Cell | Personalized cell therapy | UCLA |
|
Pre-IND/IDE or Equivalent | |
| Vascular Disease | iPS Cell | Personalized cell therapy | PAVIR |
|
Proof of Concept, Research Insights | |
|
Bladder or Urinary Tract Disorder, Incontinence |
iPS Cell | Personalized cell therapy | Stanford |
|
Pre-IND/IDE or Equivalent | |
| HIV/AIDS | Personalized cell therapy | COH |
|
IND | ||
| Amyotrophic Lateral Sclerosis | Adult Stem Cell | Personalized cell therapy | BrainStorm |
 |
Clinical Trial, Phase 3 | |
| Age-related macular degeneration | iPS Cell | Personalized cell therapy | UCLA |
|
Pre-IND/IDE or Equivalent | |
| Muscular Dystrophy |
Embryonic Stem Cell, iPS Cell |
Personalized cell therapy | UCLA |
|
Development Candidate | |
| Blood Disorders | iPS Cell | Model system development | Stanford |
|
Research Insights, Tool/Resources/Bottleneck | |
| Hearing Loss | iPS Cell | Model system development | USC |
|
Proof of Concept, Tool/Resources/Bottleneck | |
|
COVID-19, Respiratory Disorders |
Adult Stem Cell | Model system development | UCLA |
|
Development Candidate, Proof of Concept, Tool/Resources/Bottleneck | |
| Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
|
Immune Disease, Severe Combined Immunodeficiency, X-linked (X-SCID) |
Adult Stem Cell | Gene-modified, personalized cell therapy | St. Jude |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
|
Blood Disorders, Immune Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
|
Proof of Concept | |
| Multiple Myeloma | Adult Stem Cell | Gene-modified, personalized cell therapy | Poseida Therapeutics |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Epidermolysis Bullosa | iPS Cell | Gene-modified, personalized cell therapy | Stanford |
|
Pre-IND/IDE or Equivalent | |
| Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
|
IND | |
|
Hyper IgM Syndrome, Immune Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
|
Pre-IND/IDE or Equivalent | |
|
B cell cancers, Leukemia |
Adult Stem Cell | Gene-modified, personalized cell therapy | Stanford |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Sarcoma | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| HIV/AIDS | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Beta Thalassemia | Adult Stem Cell | Gene-modified, personalized cell therapy | Sangamo |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
|
Immune Disease, Leukocyte Adhesion Deficiency |
Adult Stem Cell | Gene-modified, personalized cell therapy | Rocket Pharmaceuticals, Inc. |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
|
Immune Disease, Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) |
Adult Stem Cell | Gene-modified, personalized cell therapy | Orchard Therapeutics |
 |
Clinical Trial, Phase 2 | |
|
HIV-related Lymphoma, HIV/AIDS |
Adult Stem Cell | Gene-modified, personalized cell therapy | UC Davis |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Lung Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
|
Immune Disease, X-linked Chronic Granulomatous Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
|
Cystinosis, Kidney Failure |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCSD |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
|
Pre-IND/IDE or Equivalent | |
| Cancer | Cancer Stem Cell | Gene-modified, personalized cell therapy | UCSD |
|
Pre-IND/IDE or Equivalent |
Pages
